Sunday, November 03, 2019 8:57:31 PM
Recent BGNE News
- BeiGene Provides Update on FDA Advisory Committee Vote on Benefit-Risk Profile of PD-1 Inhibitors, including TEVIMBRA®, for Treatment of ESCC and Gastric/GEJ Cancers • Business Wire • 09/26/2024 10:21:00 PM
- がん領域の世界的イノベーション企業であるベイジーン、シャリニ・シャープを役員に任命 • Business Wire • 09/26/2024 06:26:00 PM
- Globaler Onkologie-Innovator BeiGene ernennt Shalini Sharp in sein Board of Directors • Business Wire • 09/26/2024 03:37:00 PM
- BeiGene, innovateur mondial en oncologie, nomme Shalini Sharp au conseil d'administration • Business Wire • 09/26/2024 01:46:00 PM
- Global Oncology Innovator BeiGene Appoints Shalini Sharp to Board of Directors • Business Wire • 09/26/2024 10:00:00 AM
- Targeting Cancer's Achilles Heel: AI-Driven DDR Therapies Offer Hope • AllPennyStocks.com • 09/17/2024 09:01:00 PM
- BeiGene Receives Israeli Ministry of Health Approval for TEVIMBRA® for the Treatment of Oesophageal Squamous Cell Carcinoma (OSCC) After Prior Chemotherapy • Business Wire • 09/17/2024 11:00:00 AM
- Tislelizumab, inibidor PD-1 da BeiGene, é aprovado no Brasil para o tratamento de carcinoma espinocelular de esôfago (ESCC) e câncer de pulmão de células não pequenas (NSCLC) • Business Wire • 09/16/2024 12:00:00 PM
- BeiGene präsentiert TEVIMBRA®-Daten bei Lungen- und Magen-Darm-Krebs auf dem ESMO 2024 • Business Wire • 09/10/2024 06:59:00 PM
- BeiGene présente les données de TEVIMBRA® sur les cancers pulmonaires et gastro-intestinaux au Congrès de l’ESMO 2024 • Business Wire • 09/10/2024 06:59:00 PM
- BeiGene annonce la mise à jour de la formation de son équipe de direction commerciale • Business Wire • 09/09/2024 06:52:00 PM
- BeiGene gibt Wechsel im kommerziellen Führungsteam bekannt • Business Wire • 09/09/2024 06:51:00 PM
- BeiGene Announces Updates to Commercial Leadership Team • Business Wire • 09/09/2024 11:00:00 AM
- BeiGene Highlights TEVIMBRA® Data in Lung and Gastrointestinal Cancers at ESMO 2024 • Business Wire • 09/09/2024 05:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2024 11:29:23 AM
- BeiGene to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference • Business Wire • 08/28/2024 10:01:00 AM
- BeiGene’s BGB-16673 Receives U.S. FDA Fast Track Designation for CLL/SLL • Business Wire • 08/26/2024 10:00:00 AM
- ベイジーン、2024年第2四半期決算および事業に関する最新情報を発表し、グローバル成長の次なる段階へ • Business Wire • 08/08/2024 08:46:00 PM
- BeiGene公布2024年第二季財務業績和公司最新情況,進入全球成長的新階段 • Business Wire • 08/08/2024 12:23:00 PM
- BeiGene startet mit der Bekanntgabe der Finanzergebnisse des zweiten Quartals 2024 und Unternehmens-Updates in die nächste Phase seines globalen Wachstums • Business Wire • 08/08/2024 12:22:00 PM
- BeiGene entame la prochaine phase de sa croissance mondiale en annonçant ses résultats financiers du deuxième trimestre 2024 et des nouvelles de l’entreprise • Business Wire • 08/08/2024 12:22:00 PM
- Form S-4 - Registration of securities, business combinations • Edgar (US Regulatory) • 08/07/2024 11:32:45 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 10:07:59 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 10:04:19 AM
- BeiGene Enters Next Phase of Global Growth with Announcement of Second Quarter 2024 Financial Results and Corporate Updates • Business Wire • 08/07/2024 10:00:00 AM
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano Drone for Inventory Management • Oct 15, 2024 8:21 AM
Kona Gold Beverages, Inc. Announces Strategic Progress and Corporate Evolution • KGKG • Oct 15, 2024 9:00 AM
One World Products Secures First Order for Hemp-Based Reusable Containers, Pioneers Renewable Materials for the Automotive Industry • OWPC • Oct 15, 2024 8:35 AM
CBD Life Sciences, Inc. Announces Strategic MOU with U.S. Armed Forces for Groundbreaking Mushroom Supplement • CBDL • Oct 15, 2024 8:00 AM
HealthLynked Files Non-Provisional Patent for AI-Powered Healthcare Assistant, ARi • HLYK • Oct 15, 2024 8:00 AM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM